CIK 0001253689
- Non-accelerated filer
- Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +1 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition 10% owner acquired 1,270,004 shares (other)
- 4 Open-market sale 10% owner sold 322,361 shares at an average $0.19 ($61,206)
- 4 Open-market sale 10% owner sold 220,255 shares at an average $0.19 ($41,184)
- 4 Open-market sale 10% owner sold 349,764 shares at an average $0.20 ($71,097)
- 4 Open-market sale 10% owner sold 1,379,119 shares at an average $0.23 ($315,262)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 305,000 shares at an average $0.26 ($78,825)
- 4 Open-market buy SVP Finance, CFO bought 17,500 shares at $0.25 ($4,335)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 15 · 293 filings